Phase 2 Data for Crizotinib (PF-02341066) in ALK-positive Advanced Non-small Cell Lung Cancer (NSCLC): Profile 1005
Invited conference paper presented and published in conference proceedings

香港中文大學研究人員

全文

其它資訊
著者RIELY Gregory, KIM Dong-wan, CRINO Lucio, JANNE A Pasi, BLACKHALL H Fiona, CAMIDGE R David, HIRSH Vera, MOK Shu Kam Tony, SOLOMON Ben, SORIA Jean-charles, PARK Keunchil, GADGEEL M Shirish, MARTINS G Renato, HAN Ji-youn, DE PAS Tommaso, BOTTOMLEY Andrew, POLLI Anna, PETERSEN A Jennifer, TASSELL R Vanessa, SHAW T Alice
會議名稱Proceedings of the 14th World Conference on Lung Cancer
會議國家/地區美國
會議論文集題名Proceedings of the 14th World Conference on Lung Cancer
詳細描述organized by IASLC,
出版年份2011
月份6
出版地United States of America
頁次S411--S412
語言英式英語
關鍵詞Crizotinib; ALK-positive; NSCLC

上次更新時間 2018-19-01 於 22:52